A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05991349 · COMPLETED
Trial details
- NCT number
- NCT05991349
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2024-11-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.